Treatment of Vomiting Following Head Trauma
For patients with vomiting after head trauma, administer antiemetic medications (ondansetron or metoclopramide) while simultaneously evaluating for intracranial injury, as vomiting is a red flag requiring neuroimaging in most cases.
Immediate Assessment and Imaging
Vomiting after head trauma is a critical warning sign that mandates specific action:
Vomiting is a clinical decision rule criterion requiring CT imaging in patients with mild head trauma (GCS 13-15) according to the 2008 ACEP Clinical Policy 1. This applies whether the patient has loss of consciousness or not.
In children, vomiting is similarly a high-risk feature. The PECARN criteria identify vomiting as an intermediate-to-high risk factor requiring consideration of CT imaging 2.
Obtain noncontrast head CT immediately for any patient with vomiting after head trauma, as this symptom indicates increased risk of intracranial injury 3.
The rationale is straightforward: vomiting after head trauma increases the risk of intracranial pathology and potentially signals rising intracranial pressure 4. Missing an intracranial injury carries far greater morbidity and mortality risk than the radiation exposure from CT.
Antiemetic Treatment
Once imaging is obtained or in progress, provide symptomatic relief:
First-Line Antiemetic Options
Ondansetron (5-HT3 antagonist):
- Dose: 4-8 mg IV or oral 5, 4
- Advantages: Fewer CNS side effects (less drowsiness and anxiety), which is critical in head trauma patients where neurological monitoring is essential 4
- Onset: Maximum effect at 30 minutes 5
Metoclopramide (dopamine antagonist):
- Dose: 10 mg IV slow injection 5, 4
- Advantages: Faster onset (15 minutes) and prokinetic effects 5
- Disadvantages: Higher incidence of drowsiness and anxiety, which can confound neurological assessment 4
Clinical Decision Algorithm
Choose ondansetron preferentially for head trauma patients because:
- It does not cause sedation or altered mental status that could mask neurological deterioration 4
- Both medications have equivalent antiemetic efficacy 5, 4
- Preserving accurate neurological examination is paramount in head trauma
Use metoclopramide only when:
- Ondansetron is unavailable or contraindicated
- Faster onset (15 minutes vs 30 minutes) is critical
- The patient's neurological status is already definitively established
Route of Administration
- Use IV or non-oral routes when vomiting is active, as oral absorption may be impaired 6
- For severe nausea with vomiting in migraine-like post-traumatic headache, non-oral administration is specifically recommended 7
Critical Monitoring Considerations
Do not allow antiemetic treatment to delay or substitute for neuroimaging. The presence of vomiting after head trauma indicates potential intracranial pathology requiring CT evaluation 1.
Common Pitfalls to Avoid
Never assume vomiting is benign - it meets clinical decision rule criteria for imaging in both adults and children 2, 1
Avoid sedating antiemetics - metoclopramide's drowsiness and anxiety effects can mask deteriorating neurological status 4
Do not use opioids - these are contraindicated for headache management in head trauma and can confound neurological assessment 6, 8
Monitor for repeated vomiting - persistent or worsening vomiting suggests rising intracranial pressure requiring urgent neurosurgical evaluation 9
Special Populations
Children: Use the same antiemetic approach but with weight-based dosing. Nonopioid analgesics (ibuprofen or acetaminophen) can be offered for associated headache, with counseling about analgesic overuse risks 10.
Pregnant/breastfeeding patients: Discuss risks and benefits of antiemetics during pregnancy, though ondansetron has more safety data in this population 8.
Prevalence Context
Vomiting occurs in approximately 8-29% of trauma patients, with higher rates in head trauma specifically 11. The symptom is more common in older patients and females 11. Prophylactic antiemetics reduce nausea incidence from 61% to 5% in trauma patients 11, though this should not replace appropriate imaging evaluation.